Company news

Neovasc Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Neovasc Announces New Appointments in Regulatory and Clinical Leadership

July 13, 2021

Largest Real-World Registry Supporting Neovasc Reducer(TM) Safety and Efficacy Outcomes Published in International Journal of Cardiology

June 18, 2021

Neovasc Provides Corporate Update

June 10, 2021

Neovasc Reducer System Receives First National Reimbursement in Europe

June 7, 2021

Neovasc Inc. Reports Results of Annual General Meeting of Shareholders

June 3, 2021

Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

May 25, 2021

Neovasc Provides Update on German Litigation

May 20, 2021

Neovasc to Sponsor Symposium on Reducer at EuroPCR

May 13, 2021

Neovasc Announces First Patient Enrollment in COSIMA Trial

May 10, 2021

Neovasc Announces First Quarter 2021 Financial Results

May 6, 2021

Neovasc Provides Reducer Reimbursement Progress Update

April 28, 2021

Neovasc to Report First Quarter 2021 Financial Results on May 6, 2021

April 27, 2021

Neovasc Comments on EuroIntervention Article

April 19, 2021

Neovasc Provides Tiara TA Update

April 16, 2021

Neovasc Announces Fourth Quarter and Fiscal Year 2020 Financial Results

March 11, 2021

Neovasc to Report Fourth Quarter and Fiscal Year 2020 Results on March 11, 2021

March 4, 2021

Neovasc to Participate in 2021 H.C. Wainwright Global Life Sciences Conference

March 3, 2021

Neovasc Comments on Clinical Cardiology Journal Publication

March 2, 2021

Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule

February 24, 2021

Neovasc to Participate in 10th Annual SVB Leerink Global Healthcare Conference

February 17, 2021

Neovasc Announces Closing of US$72 Million Registered Direct Offering of Common Shares Priced At-The-Market

February 12, 2021

Neovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market

February 10, 2021

Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule

February 9, 2021

Neovasc Comments on Journal of the American Heart Association Publication

February 5, 2021

Neovasc Announces 2021 Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina

February 2, 2021

American Medical Association Issues New CPT Code for Neovasc Reducer Procedure

January 29, 2021

Neovasc Reducer Featured in Three Peer Reviewed Publications Supporting Reducer Therapy

January 19, 2021

Neovasc Responds to FDA Not-Approvable Letter Regarding Neovasc Reducer(TM)

January 15, 2021

Neovasc Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference

January 4, 2021

Neovasc Announces Publication of Peer-Reviewed Article in EuroIntervention

December 17, 2020

Neovasc Announces First Neovasc Reducer(TM) Implants in France

December 15, 2020

Neovasc Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

December 14, 2020

Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

December 10, 2020

Neovasc Announces Closing of US$6.1 Million Registered Direct Offering Priced At-The-Market

December 10, 2020

Neovasc Announces US$6.1 Million Registered Direct Offering Priced At-the-Market

December 8, 2020

Neovasc Announces Participation in Noble Capital Markets Virtual Road Show Series

December 1, 2020

Neovasc to Participate in Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum

November 16, 2020

Neovasc Announces Third Quarter Financial Results

November 5, 2020

Neovasc Announces FDA Advisory Panel Result on Neovasc Reducer(TM) Medical Device for the Treatment of Refractory Angina

October 28, 2020

Neovasc to Report Third Quarter Financial Results on November 5, 2020

October 22, 2020

Neovasc to Sponsor Symposium on Treating Patients with Refractory Angina at TCT Connect 2020

October 13, 2020

Neovasc to Participate in H.C. Wainwright & Co. 22nd Annual Global Investment Conference

September 8, 2020

Neovasc Inc. Reports Results of Annual General Meeting of Shareholders

September 3, 2020

Neovasc Announces Partial Prepayment of Convertible Debenture

August 17, 2020

Neovasc Provides Corporate Update

August 13, 2020

Neovasc Announces Closing of US$12.6 Million Registered Direct Offering Priced At-The-Market

August 12, 2020

Neovasc Announces US$12.6 Million Registered Direct Offering Priced At-the-Market

August 10, 2020

Neovasc Announces Second Quarter Financial Results

August 6, 2020

Neovasc Reducer(TM) Featured In Germany's Second Largest National Newspaper

July 24, 2020

Neovasc Announces Partial Prepayment of Convertible Debenture

July 23, 2020

← Newer news releases · Older news releases →

Decks

The 5 newest of 13 decks. Every deck is listed under its year.